| Name | pyr-his-trp-ser-tyr-d-lys-leu-arg-pro-gly-nh2 |
|---|---|
| Synonyms |
(D-LYS6)-GONADOTROPIN-RELEASING HORMONE
[D-LYS6]-LH-RH (HUMAN) PGLU-HIS-TRP-SER-TYR-D-LYS-LEU-G-PRO-GLY-NH2 (2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-6-amino-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[(2-amino-2-oxoethyl)cbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-cboxamide (D-LYS6)-LUTEINIZING HORMONE-RELEASING HORMONE GLP-HIS-TRP-SER-TYR-D-LYS-LEU-G-PRO-GLY-NH2 lys(6)-lhr (D-LYS6)-LUTEINIZING HORMONE-RELEASING FACTOR PYROGLU-HIS-TRP-SER-TYR-D-LYS-LEU-G-PRO-GLY NH2 LHRH, Lys [D-LYS6]-LUTEINIZING HORMONE-RELEASING HORMONE (HUMAN) Luteinizing hormone-releasing factor (swine), 6-D-lysine |
| Description | [D-Lys6]-LH-RH is a Luteinizing-hormone-releasing hormone (LHRH) analogue. [D-Lys6]-LH-RH acts as a GnRH receptor agonist[1]. |
|---|---|
| Related Catalog | |
| In Vivo | [D-Lys6]-LH-RH (100 μg, minipumps implanted subcutaneously) inhibits tumor growth in Dunning R-3327H prostate cancer rats[1]. Animal Model: Dunning R-3327H prostate cancer rats[1] Dosage: 100 μg Administration: Alzet minipumps implanted subcutaneously Result: Inhibited tumor growth compared with control. |
| Density | 1.51g/cm3 |
|---|---|
| Molecular Formula | C19H17O4P |
| Molecular Weight | 340.31000 |
| Exact Mass | 340.08600 |
| PSA | 65.57000 |
| LogP | 5.02860 |
| Index of Refraction | 1.703 |
| Risk Phrases | 60 |
|---|---|
| Safety Phrases | 53-22-36/37/39-45 |